You're reading the free version. Trader adds the live tape and alerts.
Start tracking
VRDN Award Disclosure
Gheuens Sarah · SEC Form 4 · Filed Jul 2, 2026
Award
Calculated transaction value
$0
Gheuens Sarah Director
VRDN
Transaction date
Jul 1, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 1 day later
VRDN daily price context
Close on/before transaction
$18.48
Jul 1, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 32,341 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-294552
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Viridian Therapeutics, Inc.\de VRDN Current | Award | Jul 1, 2026 | $0 |